文献速递脊柱关节炎

强直性脊柱炎患者使用高剂量与低剂量非甾体抗炎药的心血管疾病风险

Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.
PubMed 文献 · Ann Rheum Dis · 2024-07-15

基于韩国国民健康保险数据库的全国性队列研究纳入2010至2018年新诊断且无既往心血管疾病的强直性脊柱炎患者19 775例,采用时变方法评估非甾体抗炎药暴露剂量。调整混杂因素后,非甾体抗炎药剂量增加与心血管疾病风险升高相关(aHR 1.10;95%CI 1.08至1.13),缺血性心脏病、卒中和充血性心力衰竭风险均升高。

要点

  • 非甾体抗炎药剂量增加与心血管疾病风险升高相关(aHR 1.10;95%CI 1.08至1.13)。
  • 剂量增加与缺血性心脏病(aHR 1.08)、卒中(aHR 1.09)和充血性心力衰竭(aHR 1.12)风险升高相关。
  • 非甾体抗炎药剂量与心血管疾病风险的关联在不同亚组中一致。

核心结论

  • 在真实世界强直性脊柱炎队列中,较高剂量的非甾体抗炎药治疗与较高的心血管疾病风险相关,包括缺血性心脏病、卒中和充血性心力衰竭。

研究设计与样本

  • 基于韩国国民健康保险数据库的全国性队列研究,纳入2010至2018年新诊断强直性脊柱炎且无既往心血管疾病的患者19 775例(平均年龄36岁;75%为男性),其中19 706例接受非甾体抗炎药治疗。
  • 采用时变方法评估非甾体抗炎药暴露,在每个暴露期考虑非甾体抗炎药剂量,使用Cox比例风险回归分析非甾体抗炎药使用与心血管疾病风险的关联。

主要发现

  • 随访98 290人年期间发生1663例心血管疾病,包括1157例缺血性心脏病、301例卒中和613例充血性心力衰竭。
  • 调整混杂因素后,非甾体抗炎药剂量增加与心血管疾病发生相关(aHR 1.10;95%CI 1.08至1.13)。
  • 非甾体抗炎药剂量增加与缺血性心脏病发生相关(aHR 1.08;95%CI 1.05至1.11)。
  • 非甾体抗炎药剂量增加与卒中发生相关(aHR 1.09;95%CI 1.04至1.15)。
  • 非甾体抗炎药剂量增加与充血性心力衰竭发生相关(aHR 1.12;95%CI 1.08至1.16)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) associated with increasing dose of a non-steroidal anti-inflammatory drug (NSAID) in patients with ankylosing spondylitis (AS). METHODS: Using the Korean National Health Insurance database, patients newly diagnosed with AS without prior CVD between 2010 and 2018 were included in this nationwide cohort study. The primary outcome was CVD, a composite outcome of ischaemic heart disease, stroke or congestive heart failure. Exposure to NSAIDs was evaluated using a time-varying approach. The dose of NSAIDs was considered in each exposure period. Cox proportional hazard regression was used to investigate the risk of CVD associated with NSAID use. RESULTS: Of the 19 775 patients (mean age, 36 years; 75% were male), 19 706 received NSAID treatment. During follow-up period of 98 290 person-years, 1663 cases of CVD occurred including 1157 cases of ischaemic heart disease, 301 cases of stroke and 613 cases of congestive heart failure. Increasing dose of NSAIDs was associated with incident CVD after adjusting for confounders (adjusted HR (aHR) 1.10; 95% CI 1.08 to 1.13). Specifically, increasing dose of NSAIDs was associated with incident ischaemic heart disease (aHR 1.08; 95% CI 1.05 to 1.11), stroke (aHR 1.09; 95% CI 1.04 to 1.15) and congestive heart failure (aHR 1.12; 95% CI 1.08 to 1.16). The association between NSAID dose and higher CVD risk was consistent in different subgroups. CONCLUSION: In a real-world AS cohort, higher dose of NSAID treatment was associated with a higher risk of CVD, including ischaemic heart disease, stroke and congestive heart failure.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kim JW, Yoon JS, Park S, et al. Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis. Ann Rheum Dis. 2024. PMID: 38594057. doi:10.1136/ard-2023-225406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。